Price T Rowe Associates Inc. MD lifted its position in shares of AvePoint, Inc. (NASDAQ:AVPT – Free Report) by 23.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,460 shares of the company’s stock after acquiring an additional 9,801 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in AvePoint were worth $850,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. raised its holdings in AvePoint by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 15,280,202 shares of the company’s stock worth $252,276,000 after purchasing an additional 150,885 shares during the period. Wellington Management Group LLP increased its position in shares of AvePoint by 56.9% in the fourth quarter. Wellington Management Group LLP now owns 6,430,203 shares of the company’s stock valued at $106,163,000 after buying an additional 2,332,813 shares in the last quarter. Geode Capital Management LLC increased its position in shares of AvePoint by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 2,850,268 shares of the company’s stock valued at $47,067,000 after buying an additional 20,720 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in shares of AvePoint by 566.0% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,678,403 shares of the company’s stock worth $44,220,000 after buying an additional 2,276,258 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in shares of AvePoint by 7.9% during the 4th quarter. JPMorgan Chase & Co. now owns 1,657,804 shares of the company’s stock valued at $27,370,000 after buying an additional 121,144 shares in the last quarter. 44.49% of the stock is owned by hedge funds and other institutional investors.
AvePoint Stock Performance
Shares of AVPT stock opened at $18.85 on Monday. AvePoint, Inc. has a fifty-two week low of $8.15 and a fifty-two week high of $19.90. The stock’s fifty day moving average is $15.06 and its two-hundred day moving average is $16.39. The firm has a market capitalization of $3.80 billion, a P/E ratio of -376.92 and a beta of 1.30.
Insider Transactions at AvePoint
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on AVPT shares. Citigroup cut their price target on shares of AvePoint from $18.00 to $16.00 and set a “neutral” rating for the company in a report on Tuesday, March 11th. Scotiabank boosted their target price on shares of AvePoint from $19.00 to $22.00 and gave the stock a “sector outperform” rating in a research note on Friday. Finally, William Blair restated an “outperform” rating on shares of AvePoint in a research report on Tuesday, March 4th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, AvePoint has an average rating of “Moderate Buy” and an average target price of $17.00.
Get Our Latest Research Report on AvePoint
AvePoint Company Profile
AvePoint, Inc provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services.
Recommended Stories
- Five stocks we like better than AvePoint
- What is a SEC Filing?
- Constellation Powers Up With Reinforced AI Data Center Strategy
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Top Analyst-Rated Healthcare Stocks to Watch Now
- What Are Earnings Reports?
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Want to see what other hedge funds are holding AVPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AvePoint, Inc. (NASDAQ:AVPT – Free Report).
Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.